Save
2 Steps
Maximum: 1 CME cr.
Sign in to view your progression
Program overview
Educational goals
Target audience
Credit designation
Disclosures

Topic description:
This learning module summarizes the epidemiology, anatomy, etiology and associated risk factors and principles in the clinical evaluation and management of sexual pain disorders in women.

Video segments in the learning module:
- Video 1: Sexual Pain in Women: Anatomy & Assessment
- Video 2: Pelvic Floor Muscle Assessment – Triage and Physical Therapy (PT)
- Video 3: Neuroproliferative Vestibulodynia and Vulvar Dermatoses
- Video 4: Hormonally-Mediated Vestibulodynia, Neurogenic Vulvodynia, and Vestibulodynia versus Interstitial Cystitis

Faculty Information
Andrew T. Goldstein, MD, FACOG
Director, Centers for Vulvovaginal Disorders
Washington, District of Columbia and New York, New York
Clinical Professor
George Washington University School of Medicine
Washington, District of Columbia

Irwin Goldstein, MD
Director, San Diego Sexual Medicine
Director, Sexual Medicine, Alvarado Hospital
Clinical Professor of Surgery, University of California at San Diego
San Diego, California

Susan Kellogg-Spadt, PhD, CRNP, CSC
Director, Female Sexual Medicine
Center for Pelvic Medicine
Bryn Mawr, Pennsylvania
Professor, Obstetrics & Gynecology
Drexel University College of Medicine
Philadelphia, Pennsylvania
Professor, Human Sexuality
Widener University
​Chester, Pennsylvania

Best practice:
A systematic and comprehensive assessment of contributing factors associated with sexual pain will be routinely performed by the health care practitioner when evaluating the presenting complaint of sexual pain.  Based on the differential diagnosis, multimodal treatment strategies will be employed to treat sexual pain by the health care practitioner.

Current practice:
Currently, most physicians think that dyspareunia is psychological in nature or is related to infection. Systematic vulvar assessment, vulvoscopy and evaluation of the pelvic floor musculature are seldom a part of obstetrics/gynecology, primary care or urology education or clinical practice.

Resulting gaps:
Health care practitioners do not have an appreciation for the true prevalence of dyspareunia, important anatomic landmarks in the evaluation of dyspareunia, or the factors that impact sexual pain often resulting in inappropriate treatment. Health care practitioners may be unaware of the biomechanical, medical and surgical treatment strategies for dyspareunia.

Outcome indicated/Improvement in:
Health care practitioners do not have an appreciation for the true prevalence of dyspareunia, important anatomic landmarks in the evaluation of dyspareunia, or the factors that impact sexual pain often resulting in inappropriate treatment. Health care practitioners may be unaware of the biomechanical, medical and surgical treatment strategies for dyspareunia.

Learning objectives:
(1) Learn the prevalence and the three most common causes of dyspareunia.
(2) Learn the important components of the physical exam for a woman with dyspareunia.
(3) Describe the possible sources of sexual pain related to skin, musculoskeletal, neuroproliferative, hormonal and genitourinary factors and the relevant treatment options for each

Medical health care practitioners (MDs, DOs, PAs, NPs, etc.) in any field (Sexual Medicine, Obstetrics & Gynecology, Internal Medicine, Family Medicine, Urology, etc.) who would like to address sexual health in caring for their female patients.

ISSWSH Learner Notification

Module 6: Management of Sexual Pain Disorders, From Anatomy Through Diagnosis to Treatment
Dr. A. Goldstein, Dr. I. Goldstein, and Dr. S. Kellogg-Spadt

February 1, 2019 – February 1, 2021
Online

Acknowledgment of Financial Commercial Support
AMAG Pharmaceuticals, Inc

Acknowledgment of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory Completion
Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles, pass the self-assessment questionnaire with a score of 80% or higher and complete an evaluation form to receive a certificate of completion. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Continuing Education Language
Physicians

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society for the Study of Women’s Sexual Health (ISSWSH). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Amedco LLC designates this internet activity enduring material for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives - After attending this program you should be able to:

  1. Learn the prevalence and the three most common causes of dyspareunia
  2. Learn the important components of the physical exam for a woman with dyspareunia
  3. Describe the possible sources of sexual pain related to skin, musculoskeletal, neuroproliferative, hormonal and genitourinary factors and the relevant treatment options for each

The following disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.

All of these relationships were treated as a conflict of interest and have been resolved. (C7 SCS 6.1-­‐6.2, 6.5)
All individuals in a position to control the content of CE are listed below.

First

Last

Commercial Interest

Andrew

Goldstein

AMAG: Scientific/Medical Advisory Board Member, Strategic Sciences and Technology: Consultant, Endoceutics: Research Grant Overall Principal Investigator, Ipsen: Research Grant Overall Principal Investigator, Ipsen: Scientific/Medical Advisory Board Member, Lupin: Scientific/Medical Advisory Board Member

Irwin

Goldstein

Coloplast: Consultant, AbbVie: Research Grant Site Principal Investigator, AMAG: Speakers Bureau, AMAG: Research Grant Overall Principal Investigator, Duchesnay: Consultant, Strategic Science & Technologies: Consultant

Susan

Kellogg-Spadt

Materna: Consultant, Lupin: Speakers Bureau, TherapeuticsMD: Speakers Bureau, AMAG: Speakers Bureau, Lelo: Scientific/Medical Advisory Board Member, Duchesnay: Speakers Bureau

Contact information: If you have questions regarding this enduring material activity, please contact us at info@isswsh.org.

Management of Sexual Pain Disorders, from Anatomy through Diagnosis to Treatment
Self-assessment & Certificate
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings